Guillain-Barré syndrome following influenza vaccination
- PMID: 15562126
- DOI: 10.1001/jama.292.20.2478
Guillain-Barré syndrome following influenza vaccination
Abstract
Context: An unexplained increase in the risk of Guillain-Barre syndrome (GBS) occurred among recipients of the swine influenza vaccine in 1976-1977. Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990.
Objective: To evaluate trends of reports to VAERS of GBS following influenza vaccination in adults.
Design, setting, and participants: VAERS is the US national spontaneous reporting system for adverse events following vaccination. Reports of GBS in persons 18 years or older following influenza vaccination were evaluated for each influenza season from July 1, 1990, through June 30, 2003. The number of people vaccinated was estimated from the National Health Interview Survey and US census data. Beginning in 1994, active follow-up was conducted to verify GBS diagnosis and obtain other clinical details.
Main outcome measure: Reporting rates of GBS following influenza vaccination over time.
Results: From July 1990 through June 2003, VAERS received 501 reports of GBS following influenza vaccination in adults. The median onset interval (13 days) was longer than that of non-GBS reports of adverse events after influenza vaccine (1 day) (P<.001). The annual reporting rate decreased 4-fold from a high of 0.17 per 100,000 vaccinees in 1993-1994 to 0.04 in 2002-2003 (P<.001). A GBS diagnosis was confirmed in 82% of reports. Preceding illness within 4 weeks of vaccination was identified in 24% of reported cases.
Conclusions: From 1990 to 2003, VAERS reporting rates of GBS after influenza vaccination decreased. The long onset interval and low prevalence of other preexisting illnesses are consistent with a possible causal association between GBS and influenza vaccine. These findings require additional research, which can lead to a fuller understanding of the causes of GBS and its possible relationship with influenza vaccine.
Similar articles
-
Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9. Clin Infect Dis. 2014. PMID: 24415636 Review.
-
Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.Am J Epidemiol. 2013 Sep 15;178(6):962-73. doi: 10.1093/aje/kwt051. Epub 2013 May 6. Am J Epidemiol. 2013. PMID: 23652165
-
Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).J Clin Neuromuscul Dis. 2012 Dec;14(2):66-71. doi: 10.1097/CND.0b013e31824db14e. J Clin Neuromuscul Dis. 2012. PMID: 23172385
-
Guillain-Barré syndrome after exposure to influenza virus.Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Lancet Infect Dis. 2010. PMID: 20797646 Review.
-
Influenza vaccination and Guillain Barre syndrome.Clin Immunol. 2003 May;107(2):116-21. doi: 10.1016/s1521-6616(03)00046-9. Clin Immunol. 2003. PMID: 12763480
Cited by
-
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?Clin Immunol Commun. 2022 Dec;2:1-5. doi: 10.1016/j.clicom.2021.12.002. Epub 2021 Dec 23. Clin Immunol Commun. 2022. PMID: 38620684 Free PMC article. Review.
-
Immunopathogenesis of viral infections in neurological autoimmune disease.BMC Neurol. 2023 May 23;23(1):201. doi: 10.1186/s12883-023-03239-x. BMC Neurol. 2023. PMID: 37221459 Free PMC article. Review.
-
Reports of Guillain-Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database.J Clin Neurol. 2023 Mar;19(2):179-185. doi: 10.3988/jcn.2022.0237. J Clin Neurol. 2023. PMID: 36854334 Free PMC article.
-
Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study.Vaccines (Basel). 2023 Feb 17;11(2):476. doi: 10.3390/vaccines11020476. Vaccines (Basel). 2023. PMID: 36851352 Free PMC article.
-
Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan.JAMA Netw Open. 2022 Sep 1;5(9):e2232571. doi: 10.1001/jamanetworkopen.2022.32571. JAMA Netw Open. 2022. PMID: 36129709 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical